EpCAM-independent enrichment of circulating tumor cells (CTCs) in metastatic breast cancer

被引：0
|
作者：
Schneck, H. [1 ]
Gierke, B. [2 ]
Uppenkamp, F. [1 ]
Filipour, S. [1 ]
Niederacher, D. [1 ]
Stoecklein, N. [3 ]
Templin, M. [2 ]
Pawlak, M. [2 ]
Fehm, T. [1 ]
Neubauer, H. [1 ]
机构：
[1] Univ Frauenklin, Dusseldorf, Germany
[2] NMI, Reutlingen, Germany
[3] Klin Allgemein Viszeral & Kinderchirurg, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0279
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] Circulating Pancreatic Stellate Cells (Cpscs) and Tumor Cells (Ctcs) in Metastatic Pancreatic Cancer
    Pang, T.
    Xu, Z.
    Pothula, S.
    Becker, T.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Apte, M.
    PANCREAS, 2017, 46 (10) : 1425 - 1425
  • [42] Correlation of circulating tumor cells (CTCs) expressing stemness and EMT phenotypes with immunosuppressive cells in metastatic breast cancer patients
    Aggouraki, Despoina
    Papadaki, Maria
    Vetsika, Eleni Kyriaki
    Koutoulaki, Anna
    Kotsakis, Athanasios
    Kallergi, Galatea
    Agelaki, Sofia
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Circulating tumor cells as a prognostic factor independent of obesity in metastatic breast cancer patients
    Giuliano, M.
    Giordano, A.
    Patt, A.
    Hsu, L.
    Alvarez, R. H.
    Ueno, N. T.
    Valero, V.
    Hortobagyi, G. N.
    Cristofanilli, M.
    Reuben, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
    Weissenstein, Ulrike
    Schumann, Agnes
    Reif, Marcus
    Link, Susanne
    Toffol-Schmidt, Ulrike D.
    Heusser, Peter
    BMC CANCER, 2012, 12
  • [45] Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
    Ulrike Weissenstein
    Agnes Schumann
    Marcus Reif
    Susanne Link
    Ulrike D Toffol-Schmidt
    Peter Heusser
    BMC Cancer, 12
  • [46] Detection of treatment predictive biomarkers and genomic characterization of fixated circulating tumor cells (CTCs) in metastatic breast cancer
    Aaltonen, K. F.
    Jorgensen, C. Levin Tykjaer
    Ebbesson, A.
    Larsson, A. -M.
    Ryden, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Detection of circulating tumor cells (CTCs) is a prognostic factor in first-line metastatic breast cancer (MBC)
    Cristofanilli, M
    Reuben, JM
    Fritsche, HA
    Hayes, DF
    Budd, TG
    Ellis, MJ
    Stopeck, A
    Miller, CM
    Matera, J
    Allard, JW
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [48] Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
    Kallergi, G.
    Nasias, D.
    Papadaki, M.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    CANCER RESEARCH, 2012, 72
  • [49] Circulating tumor cells (CTCs) and Autologous hematopoietic stem cell transplantation in triple negative metastatic breast cancer
    Reuben, J. M.
    Mego, M.
    Gao, H.
    Ueno, N. T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S115 - S116
  • [50] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
12345